Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nuveen Multi-Marketome FundJMM -0.36%45 3-Year EPS without NRI Growth Rate is 13.70% as of Jun. 2026, which is at its 10-year median of 13.70. GuruFocus rates JMM with a GF Score™ of 45/100 and a GF Value™ of $3.97 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 849 Asset Management companies, Nuveen Multi-Marketome Fund ranks better than 51.94% on this metric.
During the past 12 months, Nuveen Multi-Marketome Fund's average EPS without NRI Growth Rate was -47.90% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 13.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 9 years, the highest 3-Year average EPS without NRI Growth Rate of Nuveen Multi-Marketome Fund was 44.20% per year. The lowest was -15.40% per year. And the median was 13.70% per year.
Nuveen Multi-Marketome Fund (NYSE:JMM) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Nuveen Multi-Marketome Fund 3-Year EPS without NRI Growth Rate Related Terms
JMM vs CCIF, RSF, MXE: 3-Year EPS without NRI Growth Rate Comparison
For the Asset Management subindustry, Nuveen Multi-Marketome Fund's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nuveen Multi-Marketome Fund 3-Year EPS without NRI Growth Rate vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Nuveen Multi-Marketome Fund's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Nuveen Multi-Marketome Fund's 3-Year EPS without NRI Growth Rate falls into.
Nuveen Multi-Marketome Fund 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 13.70% mean?
Nuveen Multi-Marketome Fund (JMM) has a 3-Year EPS without NRI Growth Rate of 13.70% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Nuveen Multi-Marketome Fund and its competitors. This is near median its historical median of 13.70. According to the industry distribution chart, Nuveen Multi-Marketome Fund ranks #408 out of 849 companies in the Asset Management industry, placing it in the top 48.1%.
Is Nuveen Multi-Marketome Fund's 3-Year EPS without NRI Growth Rate too high?
Nuveen Multi-Marketome Fund's current 3-Year EPS without NRI Growth Rate of 13.70% is near median its 10-year median of 13.70. The Asset Management industry median 3-Year EPS without NRI Growth Rate is 12.10. Nuveen Multi-Marketome Fund's value of 13.70% is 13.2% above this industry median. Based on the distribution chart, Nuveen Multi-Marketome Fund ranks #408 out of 849 companies in the Asset Management industry, which is above the industry midpoint. Overall, Nuveen Multi-Marketome Fund has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nuveen Multi-Marketome Fund's 3-Year EPS without NRI Growth Rate compare to CCIF and RSF?
According to the Asset Management industry distribution chart, Nuveen Multi-Marketome Fund ranks #408 out of 849 companies for 3-Year EPS without NRI Growth Rate. This puts Nuveen Multi-Marketome Fund in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 12.10. Nuveen Multi-Marketome Fund's value of 13.70% is 13.2% above this benchmark. While the company's 10-year median is 13.70 vs. the industry median of 12.10, Nuveen Multi-Marketome Fund has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for an Asset Management company?
The median 3-Year EPS without NRI Growth Rate among Asset Management companies is 12.10, based on 849 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nuveen Multi-Marketome Fund's current 3-Year EPS without NRI Growth Rate of 13.70% is 13.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Nuveen Multi-Marketome Fund and its competitors. For the Asset Management industry, the median 3-Year EPS without NRI Growth Rate is 12.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nuveen Multi-Marketome Fund's current 3-Year EPS without NRI Growth Rate is 13.70%, which is near median its own 10-year median of 13.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuveen Multi-Marketome Fund stock overvalued right now?
Based on GuruFocus' analysis, Nuveen Multi-Marketome Fund (JMM) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.97, compared to a current price of $5.57 — trading 40.3% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 13.70%, which is near median its 10-year median of 13.70 and 13.2% above the Asset Management industry median of 12.10. Nuveen Multi-Marketome Fund's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Nuveen Multi-Marketome Fund (JMM), the current 3-Year EPS without NRI Growth Rate is 13.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nuveen Multi-Marketome Fund (JMM) Overvalued in 2026?
Based on GuruFocus' analysis, Nuveen Multi-Marketome Fund stock appears to be overvalued.
The current stock price of $5.57 is trading 40.3% above its estimated GF Value™ of $3.97.
GuruFocus considers Nuveen Multi-Marketome Fund to be Significantly Overvalued.
Key valuation signals for JMM:
3-Year EPS without NRI Growth Rate: 13.70% (near median its 10-year median of 13.70)
GF Value™: $3.97 vs. price of $5.57 (40.3% above fair value)
Industry Position: 13.2% above the Asset Management median (#408 of 849)
No single metric tells the full story. See the JMM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities, including, but not limited to, residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.
45GF Score
Get the complete analysis for JMM
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JMM has been successfully added to your 
